Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s348724
Abstract: Abstract Advances in molecular biology and neuroscience have led to the discovery of calcitonin gene-related peptide (CGRP), a 37 amino-acid neuropeptide that plays a critical role in the pathogenesis of migraine. CGRP receptor antagonist, also… read more here.
Keywords: treatment episodic; role; atogepant treatment; role atogepant ... See more keywords